CCGG deletion (rs201074739) in CD33 results in premature termination codon and complete loss of CD33 expression: another key variant with potential impact on response to CD33-directed agents

Abstract excerpt

Acute myeloid leukemia (AML) remains difficult to treat disease. While initial complete remission (CR) rates are >80%, overall survival remains unacceptably low due to high relapse rates even with ...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Acute Myeloid Leukemia Research
• Share to Advanced biosensing and bioanalysis techniques
• Share to Protein Degradation and Inhibitors